Efficacy and Safety of LY3127804, an Anti-Angiopoietin-2 Antibody, in a Randomized, Double-Blind, PlaceboControlled Clinical Trial in Patients Hospitalized with Pneumonia and Presumed or Confirmed COVID-19

Cook, Paul P.Jones, Rosie S.2022-11-152022-11-1520221179-5484http://hdl.handle.net/10342/11742en-USAcute respiratory distress syndromeAngiopoietin 2COVID-19Efficacy and Safety of LY3127804, an Anti-Angiopoietin-2 Antibody, in a Randomized, Double-Blind, PlaceboControlled Clinical Trial in Patients Hospitalized with Pneumonia and Presumed or Confirmed COVID-19Article10.1177/11795484221119316